Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503

被引:15
|
作者
Thammavongsa, Vilasack [2 ]
Schaefer, Malinda [2 ]
Filzen, Tracey [1 ]
Collins, Kathleen L. [1 ]
Carrington, Mary [3 ]
Bangia, Naveen [4 ]
Raghavan, Malini [1 ]
机构
[1] Univ Michigan, Dept Microbiol & Immunol, Sch Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Grad Program Immunol, Sch Med, Ann Arbor, MI 48109 USA
[3] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick, Frederick, MD 21702 USA
[4] Roswell Pk Canc Inst, Dept Immunol, CCC, Buffalo, NY 14263 USA
关键词
MHC class I; Tapasin; Antigen presentation/processing; TAP transporter; HLA-B*3501; HLA-B*3503; HLA-B*4402; HLA-B*4405; HLA-B*5701; MHC CLASS-I; CYTOTOXIC T-LYMPHOCYTES; COMPLEX CLASS-I; CELL-SURFACE; HLA-B; HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; PEPTIDE BINDING; HEAVY-CHAINS;
D O I
10.1007/s00251-009-0399-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Residue 116 of major histocompatibility complex (MHC) class I heavy chains is an important determinant of assembly, that can influence rates of ER-Golgi trafficking, binding to the transporter associated with antigen processing (TAP), tapasin dependence of assembly, and the efficiency and specificity of peptide binding. Here, we investigated assembly and peptide-binding differences between HLA-B*3501(S116) and HLA-B*3503(F116), two alleles differing only at position 116 of the MHC class I heavy chain, that are associated respectively with normal or rapid AIDS progression. A reduced intracellular maturation rate was observed for HLA-B*3503 in HIV-infected and uninfected cells, which correlated with enhanced binding of HLA-B*3503 to TAP. No significant differences in the intrinsic efficiency of in vitro peptide binding by HLA-B*3501 and HLA-B*3503 were measurable with several common peptides or peptide libraries, and both allotypes were relatively tapasin-independent for their assembly. However, thermostability differences between the two allotypes were measurable in a CD4(+) T cell line. These findings suggest that compared to HLA-B*3501, a reduced intracellular peptide repertoire for HLA-B*3503 could contribute to its slower intracellular trafficking and stronger association with rapid AIDS progression.
引用
收藏
页码:703 / 716
页数:14
相关论文
共 50 条
  • [31] Characterization of a new HLA-B allele, HLA-B*5312, and re-evaluation of the published sequences of the untranslated regions of HLA-B*35 and HLA-B*53
    Heinold, A.
    Bauer, M.
    Scherer, S.
    Opelz, G.
    Tran, T. H.
    [J]. TISSUE ANTIGENS, 2007, 70 (04): : 319 - 323
  • [32] Identification of a novel HLA-B allele, HLA-B*55:81
    Ko, S. -Y.
    Im, J.
    Lee, C. K.
    Cho, Y.
    [J]. HLA, 2017, 89 (03) : 166 - U1584
  • [33] Identification of a novel HLA-B*51 variant: HLA-B*5112
    Tamouza, R
    Visser, CJT
    El Kassar, N
    Poirier, JC
    Toubert, A
    Bierling, P
    Raffoux, C
    Charron, D
    [J]. TISSUE ANTIGENS, 1998, 52 (05): : 489 - 491
  • [34] Barrett's oesophagus and HLA-B*0702/HLA-B*0706
    Rajendra, S
    Ackroyd, R
    Murad, S
    Mohan, C
    Too, CL
    Azrena, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (09) : 1375 - 1376
  • [35] The novel HLA-B allele, HLA-B*55:01:27
    Loginova, Maria
    Kutyavina, Svetlana
    Smirnova, Daria
    Paramonov, Igor
    Zarubin, Maksim
    [J]. HLA, 2021, 98 (01) : 64 - 65
  • [36] A novel HLA-B allele, HLA-B*40:01:47
    Zhu, Y. -Y.
    Qiang, W.
    Shen, G.
    Zou, J.
    Jiang, Y. -Z.
    [J]. HLA, 2016, 87 (06) : 461 - U116
  • [37] Identification of a new HLA-B*08 variant, HLA-B*0804
    Eberle, M
    Lorentzen, DF
    Iwanaga, KK
    Hennes, LF
    Watkins, DI
    [J]. TISSUE ANTIGENS, 1997, 49 (03): : 256 - 261
  • [38] A novel HLA-B allele: HLA-B*58:01:13
    Zheng, Jie W.
    Xie, Jun H.
    Sun, Ying
    Xiang, Dong
    [J]. HLA, 2019, 93 (06) : 492 - +
  • [39] Identification of a new HLA-B*55 allele, HLA-B*5503
    Williams, F
    Curran, MD
    Vaughan, RW
    Page, G
    Middleton, D
    [J]. TISSUE ANTIGENS, 1996, 48 (05): : 598 - 599
  • [40] Identification of a new HLA-B*39 allele: HLA-B*3924
    Cook, JT
    Day, S
    Dunn, PPJ
    Welsh, KI
    Bunce, M
    [J]. TISSUE ANTIGENS, 2000, 56 (02): : 178 - 179